Skip to content

Clinical trials

Completed Phase 3 Atherosclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 3 Status: Completed Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20012
20021
20038
20048
20054
20062
20075
20084
20095
20103
20112
20123
20131
20152
20164
20173
20181
20191
20202
20215
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Esperion Therapeutics, Inc.6
National Heart, Lung, and Blood Institute (NHLBI)6
Novartis Pharmaceuticals5
AstraZeneca3
Boston Scientific Corporation3
GlaxoSmithKline3
Institute for Atherosclerosis Research, Russia3
Kos Pharmaceuticals3
Organon and Co3
Abbott Medical Devices2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis81
Hypercholesterolemia21
Cardiovascular Diseases12
Coronary Disease11
Peripheral Arterial Disease9
Coronary Artery Disease8
Hyperlipidemias8
Diabetes Mellitus6
Heart Diseases6
Hypertension6

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.